Sabrina Kaiser Consortium for Astrocytoma Research (SKCAR)

As of now the “Sabrina Kaiser Consortium for Astrocytoma Research” (SKCAR) is the core element of the foundation's activities.

An initial sum of one Million Euro is being granted to five research projects focussing on improved therapies for IDH Mutant Astrocytomas (WHO 2-4).

All Projects are located in the Heidelberg-Mannheim region, and a collaborative nature of projects is encouraged. Regular consortial meetings are taking place, allowing room for exchange of ideas and methodologies.

The following outstanding researchers and their projects have been selected for funding:

Dr. Salma Baig and Dr. Sophie Heuer
Tumor networks and Cancer Neuroscience of Astrocytoma: Understanding and targeting tumor-intrinsic and extrinsic networks

Dr. Haikun Liu and Dr. Miriam Ratliff
Establishing Patient-Derived IDH Mutant Astrocytoma Organoid Biobank for Personalized Therapy

Prof. Dr. M. Platten, Prof. Dr. M. Gerstung, Dr. A. Suwala and Prof. Dr. C. Hopf
PANORAMA – spatial deconvolution of response associated immunological niches in astrocytoma

Dr. Ahmed Sadik, Dennis Friedel, OA PD Dr. med. David Reuss and Prof. Dr. Christiane Opitz
Developing inhibitors for IDH-mutant astrocytoma with worse therapy response driven by Interleukin-4 Induced 1 (IL4I1)

Dr. Dr. Varun Venkataramani, Dr. Abigail Suwala, Prof. Dr. Dr. Felix Sahm and PD Dr. Bogdana Suchorska
Integrated Analysis of Multicellular Tumor Networks During IDH-mutant Astrocytoma Progression: A Multi-modal Approach to Developing Novel Therapeutic Strategies